Skip to main content

White paper

New dimensions in life sciences research

Proving the impact on clinical outcomes as well as costs.

Using integrated data to create a dimensional view of outcomes and cost

Integrating data at scale is growing easier with advances in de-identification software, development of certified data models to protect privacy, and cloud-based computing. The resulting value is a dimensional view of outcomes and cost. Traditional analysis leaves vital information out of the value equation.

Improve decisions, enrich research and strengthen strategies

Life sciences research is benefiting from the powerful addition of integrated data. Researchers can now gain data in sufficient amounts to power robust analytics. This white paper explores how this new data can improve early business decisions, enrich research activity and strengthen market strategies.

Related healthcare insights

View all

Article

10 years of innovation with the FDA — and more in store

Dr. John Seeger reflects on Optum contributions to the Sentinel Initiative and looks forward to the opportunities ahead.

E-book

The 6 trends shaping pharma strategies in 2024

Life sciences market experts from Optum and Advisory Board share perspectives on trends that will influence the future drug value chain.

Article

Monitoring COVID-19 vaccine safety

Discover insights from Dr. John Seeger’s recent participation at the Duke-Margolis Thirteenth Annual Sentinel Initiative Public Workshop.